TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Safety and Efficacy of Nivolumab Monotherapy in Recurrent or Metastatic Cervical, Vaginal, or Vulvar Carcinoma: Results From the Phase I/II CheckMate 358 Trial.

R Wendel Naumann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.